These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 396186)

  • 21. [Immunological aspects of lung cancer].
    Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
    Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience with preoperative irradiation of 60Co gamma-ray on lung cancer].
    Kanno I; Ito Y; Oshibe M; Suzuki M
    Rinsho Hoshasen; 1967 Mar; 12(3):189-96. PubMed ID: 5183307
    [No Abstract]   [Full Text] [Related]  

  • 23. High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.
    Mizuguchi S; Inoue K; Iwata T; Nishida T; Izumi N; Tsukioka T; Nishiyama N; Uenishi T; Suehiro S
    Ann Surg Oncol; 2006 Jul; 13(7):1010-8. PubMed ID: 16788764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation].
    Takeda H; Kashimura Y; Takeoka T; Hashimoto M; Tanabe T
    Kyobu Geka; 1984 Sep; 37(10):773-7. PubMed ID: 6389949
    [No Abstract]   [Full Text] [Related]  

  • 25. [The functional state of the liver in lung cancer patients].
    Zubovskiĭ GA; Fridliand IB; Syromiatnikova EN; Riazanskaia GV
    Vopr Onkol; 1970 May; 16(5):25-9. PubMed ID: 5450806
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tumor markers in the diagnosis of lung cancer].
    Tokarskaia ZB; Surina AG; Mamakova OV
    Ter Arkh; 1983; 55(10):117-21. PubMed ID: 6196848
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disc electrophoresis with acrylamide gel. I. Preliminary considerations on some normal and pathological patterns].
    Sega E; Isabella F; Citro G
    Boll Ist Sieroter Milan; 1971; 50(5):422-8. PubMed ID: 5163529
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
    Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of long-term survival in lung neoplasms treated by radiotherapy].
    Umegaki Y; Sakura M
    Naika; 1968 Sep; 22(3):722-7. PubMed ID: 5708439
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomarkers and IL-2R in lung cancer.
    Marino P; Preatoni A; Fonticoli L; Parodi M; Tarolo GL
    Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relation between serum neuron-specific enolase and CEA levels in the patients with lung cancer].
    Hou LP
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Aug; 11(4):219-21, 255. PubMed ID: 2852546
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
    Brugarolas A; Elias EG; Takita H; Mink IB; Mittelman A; Ambrus JL
    J Med; 1973; 4(2):96-105. PubMed ID: 4127138
    [No Abstract]   [Full Text] [Related]  

  • 33. [Analysis by 2-dimensional electrophoresis of the sera of patients with lung cancer treated with schizophyllan (SPG)].
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):1021-2. PubMed ID: 6307161
    [No Abstract]   [Full Text] [Related]  

  • 34. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
    Higuchi Y
    Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood levels of alpha 1- antitrypsin in pulmonary neoplasms].
    Galietti F; Tartaglino B; Ferrua M; Ardizzi A; Barberis S
    Arch Sci Med (Torino); 1981; 138(4):497-9. PubMed ID: 6280642
    [No Abstract]   [Full Text] [Related]  

  • 36. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
    Gencer M; Ceylan E; Aksoy N; Uzun K
    Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Structural state of thrombocyte membranes and the aggregating capacity of thrombocytes in cancer of the lung].
    Rudenko TS; Zhukova NI; Kubatiev AA; Gadakchian KA; Zhdanov RI
    Patol Fiziol Eksp Ter; 1985; (5):59-62. PubMed ID: 4069788
    [No Abstract]   [Full Text] [Related]  

  • 38. Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection.
    Yeh JJ; Liu FY; Hsu WH; Wang JJ; Ho ST; Kao A
    Lung; 2002; 180(5):273-9. PubMed ID: 12489021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical significance serum N-POMC level in lung cancer patients].
    Li LY; Luo WC; Lu ZL
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):291-4. PubMed ID: 7805561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities of the use of biophysical properties of blood in superhigh frequency fields in the diagnosis of lung cancer].
    Kozhevnikov VA
    Grudn Khir; 1982; (1):74-5. PubMed ID: 7068031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.